ReviewOpen medicine (Warsaw, Poland)2022
The rationale for using low-molecular weight heparin in the therapy of symptomatic COVID-19 patients.
Edyta Reichman-Warmusz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it